The airway antigen sampling system: Respiratory M cells as an alternative gateway for inhaled antigens

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4253-4262

  Kim, Dong Young ^a,b   Sato, Ayuko ^a   Fukuyama, Satoshi ^a   Sagara, Hiroshi ^a   Nagatake, Takahiro ^a,c   Kong, Il Gyu ^a,b,c   Goda, Kaoru ^a   Nochi, Tomonori ^a   Kunisawa, Jun ^a   Sato, Shintaro ^a   Yokota, Yoshifumi ^d   Lee, Chul Hee ^b   Kiyono, Hiroshi ^a,c,e  

^a UNIVERSITY OF TOKYO   (Japan)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INHIBITOR OF DIFFERENTIATION 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EPITHELIUM CELL; IMMUNE RESPONSE; LYMPHOID TISSUE; MOUSE; NASOPHARYNX ASSOCIATED LYMPHOID TISSUE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RESPIRATORY M CELL; SALMONELLA TYPHIMURIUM; STREPTOCOCCUS GROUP A;

ADMINISTRATION, INHALATION; ANIMALS; ANTIGENS, BACTERIAL; EPITHELIAL CELLS; LYMPHOCYTE COUNT; LYMPHOID TISSUE; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, KNOCKOUT; NASAL CAVITY; NASAL MUCOSA; NASOPHARYNX; PLANT LECTINS; SALMONELLA TYPHIMURIUM; STREPTOCOCCUS PYOGENES; TURBINATES; ULEX; WHEAT GERM AGGLUTININS;

EID: 79955024162     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903794     Document Type: Article

References (38)

1. Kiyono, H., and S. Fukuyama. 2004. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat. Rev. Immunol. 4: 699-710. (Pubitemid 39223076)
2. Yuki, Y., and H. Kiyono. 2003. New generation of mucosal adjuvants for the induction of protective immunity. Rev. Med. Virol. 13: 293-310. (Pubitemid 37082192)
3. Fukuyama, S., T. Hiroi, Y. Yokota, P. D. Rennert, M. Yanagita, N. Kinoshita, S. Terawaki, T. Shikina, M. Yamamoto, Y. Kurono, and H. Kiyono. 2002. Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells. Immunity 17: 31-40. (Pubitemid 34874616)
4. Hiroi, T., K. Iwatani, H. Iijima, S. Kodama, M. Yanagita, and H. Kiyono. 1998. Nasal immune system: Distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively. Eur. J. Immunol. 28: 3346-3353. (Pubitemid 28470281)
5. Shikina, T., T. Hiroi, K. Iwatani, M. H. Jang, S. Fukuyama, M. Tamura, T. Kubo, H. Ishikawa, and H. Kiyono. 2004. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut. J. Immunol. 172: 6259-6264. (Pubitemid 38621232)
6. Shimoda, M., T. Nakamura, Y. Takahashi, H. Asanuma, S. Tamura, T. Kurata, T. Mizuochi, N. Azuma, C. Kanno, and T. Takemori. 2001. Isotype-specific selection of high affinity memory B cells in nasal-associated lymphoid tissue. J. Exp. Med. 194: 1597-1607. (Pubitemid 33126810)
7. Debertin, A. S., T. Tschernig, H. Tönjes, W. J. Kleemann, H. D. Tröger, and R. Pabst. 2003. Nasal-associated lymphoid tissue (NALT): Frequency and localization in young children. Clin. Exp. Immunol. 134: 503-507. (Pubitemid 37542092)
8. Wiley, J. A., M. P. Tighe, and A. G. Harmsen. 2005. Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasalassociated lymphoid tissue or cervical lymph nodes. J. Immunol. 175: 3186-3196. (Pubitemid 41174586)
9. Lund, F. E., S. Partida-Sánchez, B. O. Lee, K. L. Kusser, L. Hartson, R. J. Hogan, D. L. Woodland, and T. D. Randall. 2002. Lymphotoxin-alphadeficient mice make delayed, but effective, T and B cell responses to influenza. J. Immunol. 169: 5236-5243. (Pubitemid 35217195)
10. Rangel-Moreno, J., J. Moyron-Quiroz, K. Kusser, L. Hartson, H. Nakano, and T. D. Randall. 2005. Role of CXC chemokine ligand 13, CC chemokine ligand (CCL) 19, and CCL21 in the organization and function of nasal-associated lymphoid tissue. J. Immunol. 175: 4904-4913. (Pubitemid 41456372)
11. Yokota, Y., A. Mansouri, S. Mori, S. Sugawara, S. Adachi, S. Nishikawa, and P. Gruss. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397: 702-706.
12. Nochi, T., Y. Yuki, A. Matsumura, M. Mejima, K. Terahara, D. Y. Kim, S. Fukuyama, K. Iwatsuki-Horimoto, Y. Kawaoka, T. Kohda, et al. 2007. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J. Exp. Med. 204: 2789-2796. (Pubitemid 350179549)
13. Jang, M. H., M. N. Kweon, K. Iwatani, M. Yamamoto, K. Terahara, C. Sasakawa, T. Suzuki, T. Nochi, Y. Yokota, P. D. Rennert, et al. 2004. Intestinal villous M cells: An antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. USA 101: 6110-6115. (Pubitemid 38520536)
14. Hopkins, S. A., F. Niedergang, I. E. Corthesy-Theulaz, and J. P. Kraehenbuhl. 2000. A recombinant Salmonella typhimurium vaccine strain is taken up and survives within murine Peyer's patch dendritic cells. Cell. Microbiol. 2: 59-68. (Pubitemid 30225067)
15. Niedergang, F., J. C. Sirard, C. T. Blanc, and J. P. Kraehenbuhl. 2000. Entry and survival of Salmonella typhimurium in dendritic cells and presentation of recombinant antigens do not require macrophage-specific virulence factors. Proc. Natl. Acad. Sci. USA 97: 14650-14655. (Pubitemid 32016630)
16. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine. Biotechnology (N. Y.) 10: 888-892.
17. Yamamoto, M., P. Rennert, J. R. McGhee, M. N. Kweon, S. Yamamoto, T. Dohi, S. Otake, H. Bluethmann, K. Fujihashi, and H. Kiyono. 2000. Alternate mucosal immune system: Organized Peyer's patches are not required for IgA responses in the gastrointestinal tract. J. Immunol. 164: 5184-5191. (Pubitemid 30305194)
18. Todome, Y., H. Ohkuni, K. Yokomuro, Y. Kimura, S. Hamada, K. H. Johnston, and J. B. Zabriskie. 1988. Enzyme-linked immunosorbent assay of antibody to group A Streptococcus-specific C carbohydrate with trypsin-pronase-treated whole cells as antigen. J. Clin. Microbiol. 26: 464-470. (Pubitemid 18062102)
19. Matulionis, D. H., and H. F. Parks. 1973. Ultrastructural morphology of the normal nasal respiratory epithelium of the mouse. Anat. Rec. 176: 64-83.
20. Park, H. S., K. P. Francis, J. Yu, and P. P. Cleary. 2003. Membranous cells in nasal-associated lymphoid tissue: A portal of entry for the respiratory mucosal pathogen group A streptococcus. J. Immunol. 171: 2532-2537. (Pubitemid 37025563)
21. Mery, S., E. A. Gross, D. R. Joyner, M. Godo, and K. T. Morgan. 1994. Nasal diagrams: A tool for recording the distribution of nasal lesions in rats and mice. Toxicol. Pathol. 22: 353-372. (Pubitemid 24314247)
22. Adams, D. R. 1972. Olfactory and non-olfactory epithelia in the nasal cavity of the mouse, Peromyscus. Am. J. Anat. 133: 37-49.
23. Cagici, C. A., G. Karabay, C. Yilmazer, S. Gencay, and O. Cakmak. 2005. Electron microscopy findings in the nasal mucosa of a patient with stenosis of the nasal vestibule. Int. J. Pediatr. Otorhinolaryngol. 69: 399-405. (Pubitemid 40269922)
24. Jafek, B. W., B. Murrow, R. Michaels, D. Restrepo, and M. Linschoten. 2002. Biopsies of human olfactory epithelium. Chem. Senses 27: 623-628.
25. Teitelbaum, R., W. Schubert, L. Gunther, Y. Kress, F. Macaluso, J. W. Pollard, D. N. McMurray, and B. R. Bloom. 1999. The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. Immunity 10: 641-650. (Pubitemid 29302917)
26. Galen, J. E., O. G. Gomez-Duarte, G. A. Losonsky, J. L. Halpern, C. S. Lauderbaugh, S. Kaintuck, M. K. Reymann, and M. M. Levine. 1997. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15: 700-708. (Pubitemid 27240486)
27. Locht, C. 2000. Live bacterial vectors for intranasal delivery of protective antigens. Pharm. Sci. Technol. Today 3: 121-128. (Pubitemid 30195825)
28. Pasetti, M. F., T. E. Pickett, M. M. Levine, and M. B. Sztein. 2000. A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model. Vaccine 18: 3208-3213. (Pubitemid 30408196)
29. Pasetti, M. F., R. Salerno-Gonçalves, and M. B. Sztein. 2002. Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes. Infect. Immun. 70: 4009-4018. (Pubitemid 34790907)
30. Sakaue, G., T. Hiroi, Y. Nakagawa, K. Someya, K. Iwatani, Y. Sawa, H. Takahashi, M. Honda, J. Kunisawa, and H. Kiyono. 2003. HIV mucosal vaccine: Nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses. J. Immunol. 170: 495-502. (Pubitemid 36026176)
31. Imaoka, K., C. J. Miller, M. Kubota, M. B. McChesney, B. Lohman, M. Yamamoto, K. Fujihashi, K. Someya, M. Honda, J. R. McGhee, and H. Kiyono. 1998. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. J. Immunol. 161: 5952-5958. (Pubitemid 28535963)
32. Hase, K., K. Kawano, T. Nochi, G. S. Pontes, S. Fukuda, M. Ebisawa, K. Kadokura, T. Tobe, Y. Fujimura, S. Kawano, et al. 2009. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 462: 226-230.
33. Vazquez-Torres, A., J. Jones-Carson, A. J. Bäumler, S. Falkow, R. Valdivia, W. Brown, M. Le, R. Berggren, W. T. Parks, and F. C. Fang. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401: 804-808.
34. Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2: 361-367. (Pubitemid 33706348)
35. Sekine, S., K. Kataoka, Y. Fukuyama, Y. Adachi, J. Davydova, M. Yamamoto, R. Kobayashi, K. Fujihashi, H. Suzuki, D. T. Curiel, et al. 2008. A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration. J. Immunol. 180: 8126-8134.
36. Zhao, X., E. Deak, K. Soderberg, M. Linehan, D. Spezzano, J. Zhu, D. M. Knipe, and A. Iwasaki. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197: 153-162. (Pubitemid 36152310)
37. Allan, R. S., C. M. Smith, G. T. Belz, A. L. van Lint, L. M. Wakim, W. R. Heath, and F. R. Carbone. 2003. Epidermal viral immunity induced by CD8a+ dendritic cells but not by Langerhans cells. Science 301: 1925-1928. (Pubitemid 37229056)
38. Park, H. S., M. Costalonga, R. L. Reinhardt, P. E. Dombek, M. K. Jenkins, and P. P. Cleary. 2004. Primary induction of CD4 T cell responses in nasal associated lymphoid tissue during group A streptococcal infection. Eur. J. Immunol. 34: 2843-2853. (Pubitemid 39430160)